Health Conditions

Propranolol Drug Study and Nursing Interventions

 

Propranolol is the prototype of beta blocking drugs. Propranolol is the standard drug against which newer developed beta blockers compared for systemic use. Propranolol is non-selective beta blocker i.e. it can block both β1 and β2 receptors.

GENERIC NAME: Propranolol

BRAND NAME Inderal, Bedranol SR, Dositon, Sumial.

MECHANISM OF ACTION

Propranolol is non-selective beta blocker i.e. it can block both β1 and β2 receptors and possess intrinsic sympathomimetic activity (ISA). Propranolol blocks the beta receptor resulting in inhibition of sympathetic nervous system thus, decreased heart rate, delayed conduction through AV node, and reduced contractility which finally decreased the cardiac output and oxygen demand by heart muscles. Since it has weak ISA therefore it also weakly stimulate β1 and β2 receptors and leads to diminish effects on cardiac output and rate. This phenomenon is beneficial in patients who can’t tolerate other beta blockers because of pre-existing bradycardia or heart block.

PHARMACOKINETICS

Propranolol is well absorbed after oral administration. Propranolol undergoes hepatic metabolism; its bioavailability is relatively low i.e. 30%. Sustained release preparation of propranolol is available. . It is rapidly distributed in the body. Propranolol has high lipid solubility and rapidly cross the blood brain barrier. Elimination half-life is 3.5-6 hours. It is excreted little unchanged in the urine

INDICATIONS

CONTRAINDICATIONS

SIDE EFFECTS & ADVERSE EFFECTS

DRUG INTERACTION

NURSING INTERVENTIONS

PATIENT EDUCATION

 

Exit mobile version